Proteus and the University of Berne Announce New Results at BioTrans 2001.Business Editors & Health/Medical Writers BIOWIRE2K DARMSTADT, Germany--(BW HealthWire)--Sept. 4, 2001 Proteus, Nimes, France and the University of Berne, Switzerland, have published a series of new results obtained using their proprietary technology CLIPS-O(TM) at the 5th BioTrans Conference which takes place this week in Darmstadt, Germany. BioTrans is an international biannual bi·an·nu·al adj. 1. Happening twice each year; semiannual. 2. Occurring every two years; biennial. bi·an European conference series focusing on biocatalysis, biotransformation biotransformation /bio·trans·for·ma·tion/ (-trans?for-ma´shun) the series of chemical alterations of a compound (e.g., a drug) occurring within the body, as by enzymatic activity. and biotechnology and covering cutting edge research. "We are very pleased to disclose these new results obtained with Prof. Reymond of the University of Berne" said Daniel Dupret chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Proteus "We now use routinely CLIPS-O(TM) for the screening of our exclusive collection of extremophilic microorganisms as well as of novel biocatalysts generated by our proprietary L-Shuffling(TM) directed evolution Directed evolution is a method used in protein engineering to harness the power of Darwinian selection to evolve proteins or RNA with desirable properties not found in nature. technology. Results disclosed at BioTrans 2001 exemplify the relevance of CLIPS-O(TM) for the discovery of novel biomolecules This page aims to list articles on Wikipedia that describe particular biomolecules or types of biomolecules. This list is not necessarily complete or up to date - if you see an article that should be here but isn't (or one that shouldn't be here but is), please update the page under extreme conditions. CLIPS-O(TM) has now proved to provide a unique solution for sensitive and specific tests that are key to successful high throughput screening" he commented. One year ago, Proteus and the University of Bern The University of Bern is a university in the Swiss capital of Bern. It was founded in 1834. As one of the German-speaking universities in Switzerland its official name is Universität Bern, although it is frequently referred to in the French form, Université de Berne. have entered into partnership to accelerate the development of the application of this new technology which results from the investigations of Prof. Jean-Louis Reymond, one of the leading experts in biocatalysis worldwide. The collaboration has resulted in several patent applications. Proteus is a leading biotechnology company discovering and developing novel biomolecules of industrial interest. The company's activities are supported by specialist know-how and a portfolio of proprietary elements. This portfolio includes a unique microbial microbial pertaining to or emanating from a microbe. microbial digestion the breakdown of organic material, especially feedstuffs, by microbial organisms. biodiversity with a vast collection of micro-organisms originating from extreme environments and proprietary technologies for functional high throughput screening and directed evolution. Products discovered and developed by Proteus exhibit novel and/or improved activity, efficiency and stability, thus conferring competitive advantages in large global markets. To address such large markets, Proteus works in close partnership with major players of the industry. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion